Add this topic to your myFT Digest for news straight to your inbox
Pharmaceutical group’s timeline for first look at whether its trial works slips into November
Support for workers in quarantine is a crucial part of reducing the spread of Covid
More research needed to understand younger people’s milder reaction to coronavirus
Rural areas at greatest risk as intensive care beds fill up just days before elections
Paying up to $4bn for US-based biotech is unlikely to be transformational
Cyber attacks, which started two years ago, have accessed the records of 40,000 patients
Pharma groups say countries that support drug development will receive priority for successful shots
German group acquires US-based AskBio to strengthen its lucrative pharma business
Early results suggest group most vulnerable to serious illness and death could build immunity
A Dublin EMBA gave Sharon Cunningham the confidence to co-found a cancer treatment company
Investigators must bring to book the highest profile perpetrators
US regulator concludes it is safe to keep testing two major treatment candidates
Drugmaker says non-manufacturing expenses will exceed $1bn in Oxford virus project
The world must be ready to combat even more lethal virus outbreaks
Mask-wearing or curfews? A second wave is a chance to gather evidence on behavioural science
Race for an effective shot has stoked debate on price and how to support poorer countries
Retailer claims authorities put its pharmacists in impossible position over prescriptions
US agency grants first regulatory consent for a drug to treat Covid-19 patients
Migration Advisory Committee had called for loosening of post-Brexit restrictions
Members of billionaire Sackler family to pay $225m in related civil settlement
Shifts in demographics and better hospital treatments help explain rising odds of survival
Beijing has promised to help developing world but regulatory and logistical hurdles loom
International Edition
